CA1248025A - Dispositif pour la liberation d'un medicament dans le rumen des ruminants - Google Patents

Dispositif pour la liberation d'un medicament dans le rumen des ruminants

Info

Publication number: CA1248025A
Authority: CA; Canada
Prior art keywords: tube; core; sealant; devices; rumen
Prior art date: 1985-05-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000482790A

Other languages

English (en)

Inventor

Robert C. Davis

John W. Gibson

Daniel S. Skinner

Timothy E. Dearth

Dale C. Harris

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-05-30

Filing date

1985-05-30

Publication date

1989-01-03

1985-05-30 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

1985-05-30 Priority to CA000482790A priority Critical patent/CA1248025A/fr

1989-01-03 Application granted granted Critical

1989-01-03 Publication of CA1248025A publication Critical patent/CA1248025A/fr

Status Expired legal-status Critical Current

Links

210000004767 rumen Anatomy 0.000 title claims abstract description 48
239000000565 sealant Substances 0.000 claims abstract description 118
239000003814 drug Substances 0.000 claims abstract description 91
241000282849 Ruminantia Species 0.000 claims abstract description 22
239000000853 adhesive Substances 0.000 claims abstract description 19
230000001070 adhesive effect Effects 0.000 claims abstract description 19
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
238000013268 sustained release Methods 0.000 claims abstract description 10
239000012730 sustained-release form Substances 0.000 claims abstract description 10
238000012377 drug delivery Methods 0.000 claims abstract description 9
210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 8
230000009286 beneficial effect Effects 0.000 claims abstract description 5
238000011049 filling Methods 0.000 claims abstract description 4
229920000642 polymer Polymers 0.000 claims description 81
239000000463 material Substances 0.000 claims description 29
239000012943 hotmelt Substances 0.000 claims description 22
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 14
229930191564 Monensin Natural products 0.000 claims description 13
GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 claims description 13
229960005358 monensin Drugs 0.000 claims description 13
GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical group C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 claims description 13
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 12
229960005473 fenbendazole Drugs 0.000 claims description 11
230000000507 anthelmentic effect Effects 0.000 claims description 10
229920001577 copolymer Polymers 0.000 claims description 10
229910000831 Steel Inorganic materials 0.000 claims description 8
239000010935 stainless steel Substances 0.000 claims description 8
229910001220 stainless steel Inorganic materials 0.000 claims description 8
239000010959 steel Substances 0.000 claims description 8
VHKXXVVRRDYCIK-UHFFFAOYSA-N Narasin Natural products CC1CC(C)C(C(CC)C(O)=O)OC1C(C)C(O)C(C)C(=O)C(CC)C1C(C)CC(C)C2(C=CC(O)C3(OC(C)(CC3)C3OC(C)C(O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-UHFFFAOYSA-N 0.000 claims description 7
VHKXXVVRRDYCIK-CWCPJSEDSA-N Narasin Chemical compound C[C@H]1C[C@H](C)[C@H]([C@@H](CC)C(O)=O)O[C@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-CWCPJSEDSA-N 0.000 claims description 7
239000005038 ethylene vinyl acetate Substances 0.000 claims description 7
235000014655 lactic acid Nutrition 0.000 claims description 7
239000004310 lactic acid Substances 0.000 claims description 7
229960001851 narasin Drugs 0.000 claims description 7
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 7
239000004189 Salinomycin Substances 0.000 claims description 6
KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 claims description 6
229960001548 salinomycin Drugs 0.000 claims description 6
235000019378 salinomycin Nutrition 0.000 claims description 6
150000002148 esters Chemical class 0.000 claims description 5
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 claims description 4
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 claims description 4
UDKABVSQKJNZBH-DWNQPYOZSA-N Melengestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(=C)[C@](OC(=O)C)(C(C)=O)[C@@]1(C)CC2 UDKABVSQKJNZBH-DWNQPYOZSA-N 0.000 claims description 4
229960002418 ivermectin Drugs 0.000 claims description 4
229960004805 melengestrol Drugs 0.000 claims description 4
229920013716 polyethylene resin Polymers 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 3
229920001021 polysulfide Polymers 0.000 claims description 3
239000005077 polysulfide Substances 0.000 claims description 3
150000008117 polysulfides Polymers 0.000 claims description 3
150000003839 salts Chemical class 0.000 claims description 3
229930182504 Lasalocid Natural products 0.000 claims description 2
239000003242 anti bacterial agent Substances 0.000 claims description 2
239000003224 coccidiostatic agent Substances 0.000 claims description 2
239000013057 ectoparasiticide Substances 0.000 claims description 2
230000012173 estrus Effects 0.000 claims description 2
239000002917 insecticide Substances 0.000 claims description 2
BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 claims description 2
229960000320 lasalocid Drugs 0.000 claims description 2
235000016709 nutrition Nutrition 0.000 claims description 2
229920006122 polyamide resin Polymers 0.000 claims description 2
229920001296 polysiloxane Polymers 0.000 claims description 2
229920002725 thermoplastic elastomer Polymers 0.000 claims description 2
239000011573 trace mineral Substances 0.000 claims description 2
235000013619 trace mineral Nutrition 0.000 claims description 2
RFEJUZJILGIRHQ-XRIOVQLTSA-N 2,3-dihydroxybutanedioic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.OC(=O)C(O)C(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 RFEJUZJILGIRHQ-XRIOVQLTSA-N 0.000 claims 1
230000003115 biocidal effect Effects 0.000 claims 1
IRHZVMHXVHSMKB-UHFFFAOYSA-N fenbendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 IRHZVMHXVHSMKB-UHFFFAOYSA-N 0.000 claims 1
239000011162 core material Substances 0.000 description 118
238000012360 testing method Methods 0.000 description 51
241001465754 Metazoa Species 0.000 description 44
229940079593 drug Drugs 0.000 description 40
229910052751 metal Inorganic materials 0.000 description 27
239000002184 metal Substances 0.000 description 27
239000000203 mixture Substances 0.000 description 26
241000283690 Bos taurus Species 0.000 description 22
238000002360 preparation method Methods 0.000 description 19
-1 ferrous metals Chemical class 0.000 description 17
XOIQMTLWECTKJL-PDHYURILSA-M sodium;(2r,3s,4r)-4-[(2r,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2s,3r,5s)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@@H]2[C@@H](C[C@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@H](C)[C@H](OC)[C@@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-PDHYURILSA-M 0.000 description 16
238000000034 method Methods 0.000 description 15
150000001875 compounds Chemical class 0.000 description 13
239000000126 substance Substances 0.000 description 13
238000013461 design Methods 0.000 description 11
239000004459 forage Substances 0.000 description 11
229920005989 resin Polymers 0.000 description 11
239000011347 resin Substances 0.000 description 11
210000003660 reticulum Anatomy 0.000 description 11
230000003628 erosive effect Effects 0.000 description 10
HDDSHPAODJUKPD-UHFFFAOYSA-N fenbendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1SC1=CC=CC=C1 HDDSHPAODJUKPD-UHFFFAOYSA-N 0.000 description 10
229920003023 plastic Polymers 0.000 description 10
239000004033 plastic Substances 0.000 description 10
239000010963 304 stainless steel Substances 0.000 description 9
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 9
239000002253 acid Substances 0.000 description 9
239000012530 fluid Substances 0.000 description 9
230000000717 retained effect Effects 0.000 description 9
238000003466 welding Methods 0.000 description 9
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 8
238000000576 coating method Methods 0.000 description 8
239000002245 particle Substances 0.000 description 8
229920002635 polyurethane Polymers 0.000 description 8
239000004814 polyurethane Substances 0.000 description 8
229910001209 Low-carbon steel Inorganic materials 0.000 description 7
239000004698 Polyethylene Substances 0.000 description 7
230000007062 hydrolysis Effects 0.000 description 7
238000006460 hydrolysis reaction Methods 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
238000002156 mixing Methods 0.000 description 7
238000006116 polymerization reaction Methods 0.000 description 7
230000002829 reductive effect Effects 0.000 description 7
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
229940124339 anthelmintic agent Drugs 0.000 description 6
239000000921 anthelmintic agent Substances 0.000 description 6
229920000573 polyethylene Polymers 0.000 description 6
239000000047 product Substances 0.000 description 6
230000009471 action Effects 0.000 description 5
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 5
239000003054 catalyst Substances 0.000 description 5
230000000694 effects Effects 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000005259 measurement Methods 0.000 description 5
150000002739 metals Chemical class 0.000 description 5
239000002904 solvent Substances 0.000 description 5
238000005303 weighing Methods 0.000 description 5
KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 4
238000009833 condensation Methods 0.000 description 4
230000005494 condensation Effects 0.000 description 4
235000005911 diet Nutrition 0.000 description 4
230000037213 diet Effects 0.000 description 4
229920001971 elastomer Polymers 0.000 description 4
238000009472 formulation Methods 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
239000004200 microcrystalline wax Substances 0.000 description 4
235000019808 microcrystalline wax Nutrition 0.000 description 4
229920001568 phenolic resin Polymers 0.000 description 4
239000005011 phenolic resin Substances 0.000 description 4
239000005060 rubber Substances 0.000 description 4
239000000243 solution Substances 0.000 description 4
239000001993 wax Substances 0.000 description 4
230000004580 weight loss Effects 0.000 description 4
229920000459 Nitrile rubber Polymers 0.000 description 3
239000004952 Polyamide Substances 0.000 description 3
239000004809 Teflon Substances 0.000 description 3
229920006362 Teflon® Polymers 0.000 description 3
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
238000004026 adhesive bonding Methods 0.000 description 3
125000003545 alkoxy group Chemical group 0.000 description 3
125000004414 alkyl thio group Chemical group 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000010276 construction Methods 0.000 description 3
230000008602 contraction Effects 0.000 description 3
239000003822 epoxy resin Substances 0.000 description 3
238000001125 extrusion Methods 0.000 description 3
230000036449 good health Effects 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 3
230000014759 maintenance of location Effects 0.000 description 3
238000002844 melting Methods 0.000 description 3
229910052759 nickel Inorganic materials 0.000 description 3
239000004014 plasticizer Substances 0.000 description 3
229920002647 polyamide Polymers 0.000 description 3
229920000647 polyepoxide Polymers 0.000 description 3
229920005672 polyolefin resin Polymers 0.000 description 3
230000008569 process Effects 0.000 description 3
YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 3
238000003860 storage Methods 0.000 description 3
239000013589 supplement Substances 0.000 description 3
229910052718 tin Inorganic materials 0.000 description 3
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
244000025254 Cannabis sativa Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
239000004593 Epoxy Substances 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
229910000640 Fe alloy Inorganic materials 0.000 description 2
HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 2
206010016717 Fistula Diseases 0.000 description 2
241001494479 Pecora Species 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
229920006397 acrylic thermoplastic Polymers 0.000 description 2
HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 2
229960002669 albendazole Drugs 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
239000003963 antioxidant agent Substances 0.000 description 2
235000006708 antioxidants Nutrition 0.000 description 2
150000001556 benzimidazoles Chemical class 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
238000001816 cooling Methods 0.000 description 2
YADSGOSSYOOKMP-UHFFFAOYSA-N dioxolead Chemical compound O=[Pb]=O YADSGOSSYOOKMP-UHFFFAOYSA-N 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
230000003890 fistula Effects 0.000 description 2
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000001746 injection moulding Methods 0.000 description 2
239000004922 lacquer Substances 0.000 description 2
NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
230000008018 melting Effects 0.000 description 2
239000007800 oxidant agent Substances 0.000 description 2
230000000704 physical effect Effects 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920001083 polybutene Polymers 0.000 description 2
230000000379 polymerizing effect Effects 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
239000004587 polysulfide sealant Substances 0.000 description 2
150000003097 polyterpenes Chemical class 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
229960005134 pyrantel Drugs 0.000 description 2
229910000077 silane Inorganic materials 0.000 description 2
239000000344 soap Substances 0.000 description 2
241000894007 species Species 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 2
WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 2
KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
230000007704 transition Effects 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
BHFLSZOGGDDWQM-UHFFFAOYSA-N 1h-benzimidazole;carbamic acid Chemical class NC(O)=O.C1=CC=C2NC=NC2=C1 BHFLSZOGGDDWQM-UHFFFAOYSA-N 0.000 description 1
CLAGCEVKDXEHGF-UHFFFAOYSA-N 1h-benzimidazole;methylcarbamic acid Chemical class CNC(O)=O.C1=CC=C2NC=NC2=C1 CLAGCEVKDXEHGF-UHFFFAOYSA-N 0.000 description 1
229910000851 Alloy steel Inorganic materials 0.000 description 1
238000012935 Averaging Methods 0.000 description 1
108010001478 Bacitracin Proteins 0.000 description 1
229910001369 Brass Inorganic materials 0.000 description 1
239000004255 Butylated hydroxyanisole Substances 0.000 description 1
239000004322 Butylated hydroxytoluene Substances 0.000 description 1
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
229910000975 Carbon steel Inorganic materials 0.000 description 1
239000004099 Chlortetracycline Substances 0.000 description 1
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
241000209082 Lolium Species 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
229920000877 Melamine resin Polymers 0.000 description 1
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
229920001890 Novodur Polymers 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
239000004100 Oxytetracycline Substances 0.000 description 1
BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
229920001944 Plastisol Polymers 0.000 description 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
239000006087 Silane Coupling Agent Substances 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
206010057040 Temperature intolerance Diseases 0.000 description 1
241000005601 Trisetum Species 0.000 description 1
239000004182 Tylosin Substances 0.000 description 1
229930194936 Tylosin Natural products 0.000 description 1
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229960003071 bacitracin Drugs 0.000 description 1
229930184125 bacitracin Natural products 0.000 description 1
CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
238000009835 boiling Methods 0.000 description 1
239000010951 brass Substances 0.000 description 1
239000012267 brine Substances 0.000 description 1
235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
229940043253 butylated hydroxyanisole Drugs 0.000 description 1
235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
229940095259 butylated hydroxytoluene Drugs 0.000 description 1
229910052793 cadmium Inorganic materials 0.000 description 1
BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
244000309466 calf Species 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
150000005829 chemical entities Chemical class 0.000 description 1
235000015111 chews Nutrition 0.000 description 1
CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
229960004475 chlortetracycline Drugs 0.000 description 1
235000019365 chlortetracycline Nutrition 0.000 description 1
CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000007906 compression Methods 0.000 description 1
230000006835 compression Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
238000005260 corrosion Methods 0.000 description 1
230000007797 corrosion Effects 0.000 description 1
239000007822 coupling agent Substances 0.000 description 1
238000002788 crimping Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
150000004985 diamines Chemical class 0.000 description 1
239000012975 dibutyltin dilaurate Substances 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
235000013325 dietary fiber Nutrition 0.000 description 1
238000007865 diluting Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
239000004205 dimethyl polysiloxane Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
239000013536 elastomeric material Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
229920006332 epoxy adhesive Polymers 0.000 description 1
125000003700 epoxy group Chemical group 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
RSRHQRPZSHOGSB-UHFFFAOYSA-N ethyl 6-decoxy-7-ethoxy-4-hydroxy-1,4-dihydroquinoline-3-carboxylate Chemical compound OC1C(C(=O)OCC)=CNC2=C1C=C(OCCCCCCCCCC)C(OCC)=C2 RSRHQRPZSHOGSB-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
229960005282 febantel Drugs 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
238000005187 foaming Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
238000005227 gel permeation chromatography Methods 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
125000006331 halo benzoyl group Chemical group 0.000 description 1
230000036541 health Effects 0.000 description 1
230000008543 heat sensitivity Effects 0.000 description 1
150000002430 hydrocarbons Chemical group 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000011256 inorganic filler Substances 0.000 description 1
229910003475 inorganic filler Inorganic materials 0.000 description 1
230000000749 insecticidal effect Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
229960001614 levamisole Drugs 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
235000001055 magnesium Nutrition 0.000 description 1
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
150000007974 melamines Chemical class 0.000 description 1
239000000155 melt Substances 0.000 description 1
229950003442 methoprene Drugs 0.000 description 1
229930002897 methoprene Natural products 0.000 description 1
239000003607 modifier Substances 0.000 description 1
239000002991 molded plastic Substances 0.000 description 1
229910052750 molybdenum Inorganic materials 0.000 description 1
239000011733 molybdenum Substances 0.000 description 1
239000000178 monomer Substances 0.000 description 1
238000000465 moulding Methods 0.000 description 1
JNEZCZPNQCQCFK-UHFFFAOYSA-N n-[4-[2-[2-(4-acetamidophenoxy)ethoxy]ethoxy]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1OCCOCCOC1=CC=C(NC(C)=O)C=C1 JNEZCZPNQCQCFK-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
229960000625 oxytetracycline Drugs 0.000 description 1
235000019366 oxytetracycline Nutrition 0.000 description 1
IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000003973 paint Substances 0.000 description 1
244000045947 parasite Species 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
238000005453 pelletization Methods 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000004999 plastisol Substances 0.000 description 1
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920002689 polyvinyl acetate Polymers 0.000 description 1
239000011118 polyvinyl acetate Substances 0.000 description 1
IWZKICVEHNUQTL-UHFFFAOYSA-M potassium hydrogen phthalate Chemical compound [K+].OC(=O)C1=CC=CC=C1C([O-])=O IWZKICVEHNUQTL-UHFFFAOYSA-M 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000000063 preceeding effect Effects 0.000 description 1
238000003825 pressing Methods 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
238000005488 sandblasting Methods 0.000 description 1
238000004826 seaming Methods 0.000 description 1
229910052711 selenium Inorganic materials 0.000 description 1
239000011669 selenium Substances 0.000 description 1
239000004460 silage Substances 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
239000004590 silicone sealant Substances 0.000 description 1
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
229920003048 styrene butadiene rubber Polymers 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
235000001508 sulfur Nutrition 0.000 description 1
230000000153 supplemental effect Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
239000004416 thermosoftening plastic Substances 0.000 description 1
235000010296 thiabendazole Nutrition 0.000 description 1
229960004546 thiabendazole Drugs 0.000 description 1
239000004308 thiabendazole Substances 0.000 description 1
239000011135 tin Substances 0.000 description 1
KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 description 1
150000003609 titanium compounds Chemical class 0.000 description 1
238000004448 titration Methods 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
231100000816 toxic dose Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
229960004059 tylosin Drugs 0.000 description 1
235000019375 tylosin Nutrition 0.000 description 1
WBPYTXDJUQJLPQ-VMXQISHHSA-N tylosin Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@@H]1[C@@H](C)[C@H](O)CC(=O)O[C@@H]([C@H](/C=C(\C)/C=C/C(=O)[C@H](C)C[C@@H]1CC=O)CO[C@H]1[C@@H]([C@H](OC)[C@H](O)[C@@H](C)O1)OC)CC)[C@H]1C[C@@](C)(O)[C@@H](O)[C@H](C)O1 WBPYTXDJUQJLPQ-VMXQISHHSA-N 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
230000004584 weight gain Effects 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1
238000009736 wetting Methods 0.000 description 1
239000002023 wood Substances 0.000 description 1
239000011701 zinc Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
229940105296 zinc peroxide Drugs 0.000 description 1

Landscapes

Medicinal Preparation (AREA)

CA000482790A 1985-05-30 1985-05-30 Dispositif pour la liberation d'un medicament dans le rumen des ruminants Expired CA1248025A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000482790A CA1248025A (fr)	1985-05-30	1985-05-30	Dispositif pour la liberation d'un medicament dans le rumen des ruminants

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA000482790A CA1248025A (fr)	1985-05-30	1985-05-30	Dispositif pour la liberation d'un medicament dans le rumen des ruminants

Publications (1)

Publication Number	Publication Date
CA1248025A true CA1248025A (fr)	1989-01-03

Family

ID=4130592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000482790A Expired CA1248025A (fr)	1985-05-30	1985-05-30	Dispositif pour la liberation d'un medicament dans le rumen des ruminants

Country Status (1)

Country	Link
CA (1)	CA1248025A (fr)

1985
- 1985-05-30 CA CA000482790A patent/CA1248025A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2006-01-03	MKEX	Expiry

Publication	Publication Date	Title
US4649042A (en)	1987-03-10	Rumen delivery device
AU650113B2 (en)	1994-06-09	Sustained release capsule and formulations
KR100370985B1 (ko)	2003-04-11	소속동물에게유체-민감성소마토트로핀의전달을위한삼투계
US4774092A (en)	1988-09-27	Ingestible capsules
US5180591A (en)	1993-01-19	Delivery device with a protective sleeve
US5137727A (en)	1992-08-11	Delivery device providing beneficial agent stability
KR0132212B1 (ko)	1998-04-11	체계속으로서의 유체의 잠입을 조절하는 수단을 포함하는 전달 시스템
CA1236009A (fr)	1988-05-03	Forme posologique a liberation continue a base de gels d'ether de cellulose hautement plasticises
AU642704B2 (en)	1993-10-28	Long-term delivery device including loading dose
DE3625915C2 (de)	1997-04-24	Abgabevorrichtung zur Freisetzung eines Wirkstoffs
EP0537998A1 (fr)	1993-04-21	Dispositif d'administration de médicaments à libération contrôlée comprenant une matrice de polymère et un plastifiant
EP0458887A1 (fr)	1991-12-04	Dispositif de distribution
JPH10508023A (ja)	1998-08-04	射出成形された投与剤型
CA1248025A (fr)	1989-01-03	Dispositif pour la liberation d'un medicament dans le rumen des ruminants
CA1298527C (fr)	1992-04-07	Procede d'introduction d'un agent a haute densite
NZ227772A (en)	1991-06-25	High density intra-ruminal bolus having a compacted and unsintered metal weight
JPS612850A (ja)	1986-01-08	持効性薬剤放出装置
KR890001179B1 (ko)	1989-04-26	지속적으로 방출되는 복용체
Conrad et al.	1989	Controlled sustained delivery of monensin in cattle: The monensin RDD®
CN1138527C (zh)	2004-02-18	延时启动药剂的发送并完全释放药剂的渗透装置
AU618318B2 (en)	1991-12-19	Intraruminal drug delivery device
EP0263691A2 (fr)	1988-04-13	Capsule vétérinaire à densité élevée
AU708219B2 (en)	1999-07-29	Sustained release capsule and formulations
AU4453699A (en)	2000-03-09	Sustained release capsule and formulations